CII
BHVN

Capital International Inc’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Capital International Inc’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,350
Closed -$2.77M – 306
2022
Q1 		$2.77M Sell
23,350
-7,986
-25% -$996K 0.03% 215
2021
Q4 		$4.32M Sell
31,336
-442,142
-93% -$56.2M 0.04% 211
2021
Q3 		$65.8M Sell
473,478
-74,299
-14% -$9.28M 0.63% 58
2021
Q2 		$53.2M Sell
547,777
-35,590
-6% -$2.89M 0.47% 73
2021
Q1 		$39.9M Sell
583,367
-74,013
-11% -$5.99M 0.37% 99
2020
Q4 		$56.3M Sell
657,380
-79,609
-11% -$6.75M 0.52% 66
2020
Q3 		$47.9M Sell
736,989
-334,877
-31% -$21.9M 0.53% 61
2020
Q2 		$78.4M Buy
1,071,866
+11,973
+1% +$637K 0.96% 30
2020
Q1 		$36.1M Sell
1,059,893
-80,208
-7% -$3.67M 0.61% 66
2019
Q4 		$62.1M Sell
1,140,101
-1,142
-0.1% -$56.5K 0.86% 41
2019
Q3 		$47.6M Buy
1,141,243
+1,083,931
+1,891% +$45.8M 0.72% 58
2019
Q2 		$2.51M Buy
+57,312
New +$3.23M 0.18% 113

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Inc's BHVN Position: Q2 2022 in Review

Capital International Inc sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 23,350 shares — an estimated $2.77M sold.

Capital International Inc first reported a position in BHVN in Q2 2019 and held it in 12 quarters. The position peaked at $78.4M in Q2 2020. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • Capital International Inc reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • Capital International Inc sold 23,350 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $2.77M.
  • Capital International Inc first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 12 quarters.
  • Capital International Inc's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $78.4M in Q2 2020.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Capital International Inc's 13F filing for Q2 2022, filed 15 Aug 2022.